465 related articles for article (PubMed ID: 7686468)
1. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.
Peters DH; Sorkin EM
Drugs; 1993 May; 45(5):760-87. PubMed ID: 7686468
[TBL] [Abstract][Full Text] [Related]
2. An assessment of zonisamide as an anti-epileptic drug.
Jain KK
Expert Opin Pharmacother; 2000 Sep; 1(6):1245-60. PubMed ID: 11249491
[TBL] [Abstract][Full Text] [Related]
3. Zonisamide in the management of epilepsy--Japanese experience.
Ohtahara S
Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
[TBL] [Abstract][Full Text] [Related]
4. [Research and development of zonisamide, a new type of antiepileptic drug].
Shimizu M; Uno H; Ito T; Masuda Y; Kurokawa M
Yakugaku Zasshi; 1996 Jul; 116(7):533-47. PubMed ID: 8831258
[TBL] [Abstract][Full Text] [Related]
5. Zonisamide: review of its use in epilepsy therapy.
Zareba G
Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
Baulac M; Leppik IE
Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
Frampton JE; Scott LJ
CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy.
Goa KL; Ross SR; Chrisp P
Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504
[TBL] [Abstract][Full Text] [Related]
9. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
Palmer KJ; McTavish D
Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
[TBL] [Abstract][Full Text] [Related]
10. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
[TBL] [Abstract][Full Text] [Related]
11. Zonisamide in pediatric epilepsy: review of the Japanese experience.
Glauser TA; Pellock JM
J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
[TBL] [Abstract][Full Text] [Related]
12. Introduction to zonisamide.
Baulac M
Epilepsy Res; 2006 Feb; 68 Suppl 2():S3-9. PubMed ID: 16413170
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and drug interactions with zonisamide.
Sills G; Brodie M
Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
Fitton A; Goa KL
Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
[TBL] [Abstract][Full Text] [Related]
15. Zonisamide: its pharmacology, efficacy and safety in clinical trials.
Brodie MJ; Ben-Menachem E; Chouette I; Giorgi L
Acta Neurol Scand Suppl; 2012; (194):19-28. PubMed ID: 23106522
[TBL] [Abstract][Full Text] [Related]
16. Zonisamide: new drug. No advantage in refractory partial epilepsy.
Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
Kothare SV; Kaleyias J
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
Davis R; Peters DH; McTavish D
Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
[TBL] [Abstract][Full Text] [Related]
19. Overview of Japanese experience-controlled and uncontrolled trials.
Yagi K
Seizure; 2004 Dec; 13 Suppl 1():S11-5; discussion S16. PubMed ID: 15511680
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide: pharmacokinetics, efficacy, and adverse events in children with epilepsy.
Wallander KM; Ohman I; Dahlin M
Neuropediatrics; 2014 Dec; 45(6):362-70. PubMed ID: 25133701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
